News & Events
< Back to News Overview
CogState Signs Agreement in "Smart Foods" / Complementary Medicine Sector with Total Revenue of $306,000
22 / 08 / 2005
CogState Ltd (ASX:CGS) announces today that they have signed an agreement with a European food-products company to study the effect of certain of their food products on cognitive function.
The total revenue under the agreement will be $306,000. CogState has previously invoiced approximately $40,000 under a separate agreement for the design of the study.
Under the new agreement, CogState will manage the conduct of the study and provide cognition testing services. The study will be conducted by the CSIRO and completed by the end of the calendar year.
Dr. Adam Whybrew, Head of Sales and Marketing for CogState comments "CogState has already been involved in three smaller studies in the "smart foods" and complementary medicine sectors. The scientific expertise gained from these has allowed our recently-opened London office to win this significant contract. We believe this will be the first of many, on account of the growing interest in cognition in these expanding sectors".
For more information, please contact Dr Adam Whybrew or CogState CEO, Dr. Peter Bick on 03 9664 1300.
The total revenue under the agreement will be $306,000. CogState has previously invoiced approximately $40,000 under a separate agreement for the design of the study.
Under the new agreement, CogState will manage the conduct of the study and provide cognition testing services. The study will be conducted by the CSIRO and completed by the end of the calendar year.
Dr. Adam Whybrew, Head of Sales and Marketing for CogState comments "CogState has already been involved in three smaller studies in the "smart foods" and complementary medicine sectors. The scientific expertise gained from these has allowed our recently-opened London office to win this significant contract. We believe this will be the first of many, on account of the growing interest in cognition in these expanding sectors".
For more information, please contact Dr Adam Whybrew or CogState CEO, Dr. Peter Bick on 03 9664 1300.